超声微泡介导的miR-21和miR-126克服紫杉醇耐药乳腺癌的实验研究

doi:10.3969/j.issn.1001-8131.2024.03.001

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (569 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the effects of ultrasound-mediatedmiR-21 and miR-126 on paclitaxel resistance in breast cancer. Methods 50 subcutaneous breast cancer transplantation tumormodels established by drug-resistant breast cancer cells were selected as research objects.Ultrasonicmicrovesicles loaded withmiR-21 and miR-126 were prepared and randomly divided into control group,empty microvesicles group,miR-21microvesicles group,miR-126microvesicles group and combination group with 10mice in each group.Tumor growth ofmice in each group was observed.Tumor growth curve was plotted and tumor inhibition rate was calculated.Real-time fluorescence quantitative RT-PCR was used to detect the levels ofmiR-21 andmiR-126 in tumor tissues,and immunohistochemistry was used to detect the protein expression levels of breast cancer drug-resistant protein（BCRP）,p-glycoprotein（P-gp）and drug-resistant drug-related protein 1（mRP1）in tumor tissues. Results Compared with the control group and the vacuole group,the miR-21mRNA expression level in themiR-21microbubble group and the combined miR-126microbubble group was significantly down-regulated（P<0.05）,while the miR-126microbubble group and the combinedmiR-126mrna expression level was significantly up-regulated（P<0.05）.The tumor volume in the control group and the vacuole group continued to increase.Compared with the control group and the vacuole group,the combined group had the smallest tumor volume andmass,and the highest tumor volume andmass inhibitory rate（P<0.05）,followed by themiR-21 microvesicle group andmiR-126microvesicle group（P<0.05）.Immunohistochemical results showed that the positive rates of BCRP,P-GP andmRP1 in the combination group were 20.00%,10.00% and 20.00%,respectively,which were significantly lower than those ofmiR-126microbubble group andmiR-21microbubble group（P<0.05）. Conclusion The combined intervention ofmiR-21 andmiR-126mediated by ultrasonicmicrovesicle has a synergistic inhibitory effect on the growth of subcutaneous graft tumors in paclitaxel-resistantmice,providing a new therapeutic approach and target for overcoming paclitaxel-resistant breast cancer.

Key words： breast cancer Drug resistance Ultrasonicmicrobubble miR-21 miR-126

Received: 05 March 2024

PACS:

R737.9

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Weng Peihua

Cite this article:

Weng Peihua. Ultrasound-mediatedmiR-21and miR-126overcome Paclitaxel-resistant Breast Cancer[J]. journal1, 2024, 44(3): 1-4.

URL:

http://www.hrbyybjb.org.cn/EN/10.3969/j.issn.1001-8131.2024.03.001 OR http://www.hrbyybjb.org.cn/EN/Y2024/V44/I3/1

[1] Kashyap D,Pal D,Sharma R,et al. Global Increase in Breast Cancer Incidence:Risk Factors and Preventivemeasures[J].Biomed Res Int.2022,2022:9605439.
[2] 桑蝶,周华,宗红,等.白蛋白紫杉醇治疗晚期乳腺癌疗效和安全性的多中心真实世界研究[J].中华肿瘤杂志,2021,43(10):1114-1121.
[3] Dan Vm,Raveendran RS,Baby S.Resistance to Intervention:Paclitaxel in Breast Cancer[J].mini Revmed Chem.2021,21(10):1237-1268.
[4] 杨国良,杨君,唐君辉,等.精准医疗时代下超声靶向微泡破坏技术研究与应用[J].医学综述,2021,27(24):4939-4945.
[5] 于姣姣,査莉,朱艳艳,等.超声微泡介导miRNAs 在肿瘤治疗中的应用进展[J].现代肿瘤医学,2022,30(18):3415-3418.
[6] 蔡颖.miRNA-125b和miRNA-21对人乳腺癌紫杉醇耐药细胞株耐药性影响的研究[D].蚌埠医学院,2014.
[7] 王婷,吴双华,谢璨灿,等.黄芩苷通过上调miR-126 基因抑制乳腺癌细胞增殖[J].中国免疫学杂志,2022,38(5):551-556.
[8] 李敏,王健宝,杨大艳.超声微泡介导miR-126 通过调节CRK抑制乳腺癌细胞生长[J].中国免疫学杂志,2020,36(16):1967-1972.
[9] Liang WH,Zhang WW,Zhao SF,et al.A study of the ultrasoundtargetedmicrobubble destruction based triplex-forming oligodexinucleotide delivery system to inhibit tissue factor expression[J].molmed Rep,2015,11(2):903-909.
[10] Subramaniam S,Yugo Dm,Heffron CL,et al.Vaccination of sows with a dendritic cell-targeted porcine epidemic diarrhea virus S1 protein-based candidate vaccine reduced viral shedding but exacerbated gross pathological lesions in suckling neonatal piglets[J].J Gen Virol,2018,99(2):230-239.
[11] Coughlin SS.Epidemiology of breast cancer in women[J].Adv Expmed Biol,2019,1152:9-29.
[12] 李娜,张哲莹,朱会芳,等.miR-7-5p和miR-152-3p 联合调控Wnt/β-catenin通路对乳腺癌细胞上皮-间质转化及化疗耐药的影响[J].临床与实验病理学杂志,2021,37(7):765-770.
[13] 赵杨,钟山亮,张晓慧,等.miR-21靶向调节mARCKS 基因影响人乳腺癌细胞多西紫杉醇敏感性的研究[J].现代生物医学进展,2018,18(7):1217-1221.
[14] 罗利云,贾小婷,郑国沛,等.miR-126介导的IGF2/IGF1R/IRS1信号活化促进ErbB2阳性乳腺癌细胞对Herceptin的耐受[J].中国医师杂志,2017,19(2):163-167.
[15] 翁沛华.超声-微泡介导miR-128通过调节PTEN抑制乳腺癌细胞阿霉素耐药[J].广州医药,2021,52(6):35-38.